dactinomycin
Generic: dactinomycin
Labeler: xgen pharmaceuticals djb, inc.Drug Facts
Product Profile
Brand Name
dactinomycin
Generic Name
dactinomycin
Labeler
xgen pharmaceuticals djb, inc.
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
dactinomycin .5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
39822-2100
Product ID
39822-2100_19853d49-64c6-f1cd-e063-6294a90a9c95
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203999
Listing Expiration
2026-12-31
Marketing Start
2019-07-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
398222100
Hyphenated Format
39822-2100
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dactinomycin (source: ndc)
Generic Name
dactinomycin (source: ndc)
Application Number
ANDA203999 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (39822-2100-2) / 1 mL in 1 VIAL, SINGLE-DOSE (39822-2100-1)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "19853d49-64c6-f1cd-e063-6294a90a9c95", "openfda": {"nui": ["N0000180850", "N0000000233", "N0000000150"], "unii": ["1CC1JFE158"], "rxcui": ["239179"], "spl_set_id": ["efe03d73-eb11-45ff-a3cb-09a540ed352f"], "pharm_class_epc": ["Actinomycin [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["XGen Pharmaceuticals DJB, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (39822-2100-2) / 1 mL in 1 VIAL, SINGLE-DOSE (39822-2100-1)", "package_ndc": "39822-2100-2", "marketing_start_date": "20190731"}], "brand_name": "dactinomycin", "product_id": "39822-2100_19853d49-64c6-f1cd-e063-6294a90a9c95", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Actinomycin [EPC]", "Nucleic Acid Synthesis Inhibitors [MoA]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "39822-2100", "generic_name": "dactinomycin", "labeler_name": "XGen Pharmaceuticals DJB, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "dactinomycin", "active_ingredients": [{"name": "DACTINOMYCIN", "strength": ".5 mg/mL"}], "application_number": "ANDA203999", "marketing_category": "ANDA", "marketing_start_date": "20190731", "listing_expiration_date": "20261231"}